Skip to main content
Erschienen in: Pituitary 4/2009

01.12.2009

Ghrelin and GHRP-6-induced ACTH and cortisol release in thyrotoxicosis

verfasst von: Sergio Oliva Nascif, Patrícia Molica, Silvia Regina Correa-Silva, Marcos Roberto Silva, Ana-Maria Judith Lengyel

Erschienen in: Pituitary | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Thyrotoxicosis might alter the hypothalamic-pituitary-adrenal (HPA) axis. We evaluated the effects of ghrelin and GHRP-6 on the HPA axis in 20 hyperthyroid patients and in 9 controls. Mean basal cortisol (μg/dl) and ACTH (pg/ml) levels were higher in hyperthyroidism (cortisol: 10.7 ± 0.7; ACTH: 21.5 ± 2.9) compared to controls (cortisol: 8.1 ± 0.7; ACTH: 13.5 ± 1.8). In thyrotoxicosis ∆ AUC cortisol values (μg/dl.90 min) after ghrelin (484 ± 80) and GHRP-6 (115 ± 63) were similar to controls (ghrelin: 524 ± 107; GHRP-6: 192 ± 73). A significant increase in ∆ AUC ACTH (pg/ml.90 min) after ghrelin was observed in thyrotoxicosis (4,189 ± 1,202) compared to controls (1,499 ± 338). ∆ AUC ACTH values after GHRP-6 were also higher, although not significantly (patients: 927 ± 330; controls: 539 ± 237). In summary, our results suggest that ghrelin-mediated pathways of ACTH release might be activated by thyroid hormone excess, but adrenocortical reserve is maintained.
Literatur
1.
Zurück zum Zitat Melmed S, Kleinberg D (2008) Anterior Pituitary. In: Kronenberg HM (ed) Williams textbook of endocrinology, 11th edn. Saunders Elsevier, Philadelphia, pp 155–261 Melmed S, Kleinberg D (2008) Anterior Pituitary. In: Kronenberg HM (ed) Williams textbook of endocrinology, 11th edn. Saunders Elsevier, Philadelphia, pp 155–261
2.
Zurück zum Zitat Levin ME, Daughaday WH (1955) The influence of the thyroid on adrenocortical function. J Clin Endocrinol Metab 15:1494–1510CrossRef Levin ME, Daughaday WH (1955) The influence of the thyroid on adrenocortical function. J Clin Endocrinol Metab 15:1494–1510CrossRef
4.
Zurück zum Zitat Gordon GG, Southren AL (1977) Thyroid-hormone effects on steroid-hormone metabolism. Bull N Y Acad Med 53:241–254PubMed Gordon GG, Southren AL (1977) Thyroid-hormone effects on steroid-hormone metabolism. Bull N Y Acad Med 53:241–254PubMed
5.
Zurück zum Zitat Jackson IMD, Hassan THA, Prentice CRM, Browning MCK (1966) Insulin-induced hypoglycemia as a test of pituitary-adrenal function in thyrotoxicosis. J Clin Endocrinol 26:545–549CrossRef Jackson IMD, Hassan THA, Prentice CRM, Browning MCK (1966) Insulin-induced hypoglycemia as a test of pituitary-adrenal function in thyrotoxicosis. J Clin Endocrinol 26:545–549CrossRef
8.
Zurück zum Zitat Yamakita N, Murai T, Kokubo Y, Hayashi M, Akai A, Yasuda K (2001) Dehydroepiandrosterone sulphate is increased and dehydroepiandrosterone-response to corticotrophin-releasing hormone is decreased in the hyperthyroid state compared with the euthyroid state. Clin Endocrinol (Oxf) 55:797–803. doi:10.1046/j.1365-2265.2001.01420.x CrossRef Yamakita N, Murai T, Kokubo Y, Hayashi M, Akai A, Yasuda K (2001) Dehydroepiandrosterone sulphate is increased and dehydroepiandrosterone-response to corticotrophin-releasing hormone is decreased in the hyperthyroid state compared with the euthyroid state. Clin Endocrinol (Oxf) 55:797–803. doi:10.​1046/​j.​1365-2265.​2001.​01420.​x CrossRef
9.
Zurück zum Zitat Giustina G, Reschini E, Valentini F, Cantalamessa L (1971) Growth hormone and cortisol responses to insulin-induced hypoglycemia in thyrotoxicosis. J Clin Endocrinol 32:571–574CrossRef Giustina G, Reschini E, Valentini F, Cantalamessa L (1971) Growth hormone and cortisol responses to insulin-induced hypoglycemia in thyrotoxicosis. J Clin Endocrinol 32:571–574CrossRef
10.
Zurück zum Zitat Brauman H, Smets P, Corvilain J (1973) Comparative study of growth response to hypoglycemia in normal subjects and in patients with primary myxedema or hyperthyroidism before and after treatment. J Clin Endocrinol Metab 36:1162–1174CrossRefPubMed Brauman H, Smets P, Corvilain J (1973) Comparative study of growth response to hypoglycemia in normal subjects and in patients with primary myxedema or hyperthyroidism before and after treatment. J Clin Endocrinol Metab 36:1162–1174CrossRefPubMed
12.
Zurück zum Zitat Dumoulin SC, Perret BP, Bennet AP, Caron PJ (1995) Opposite effects of thyroid hormones on binding proteins for steroid hormones (sex hormone-binding globulin and corticosteroid-binding globulin) in humans. Eur J Endocrinol 132:594–598. doi:10.1530/eje.0.1320594 CrossRefPubMed Dumoulin SC, Perret BP, Bennet AP, Caron PJ (1995) Opposite effects of thyroid hormones on binding proteins for steroid hormones (sex hormone-binding globulin and corticosteroid-binding globulin) in humans. Eur J Endocrinol 132:594–598. doi:10.​1530/​eje.​0.​1320594 CrossRefPubMed
13.
Zurück zum Zitat Mishra SK, Gupta N, Goswami R (2007) Plasma adrenocorticotropin (ACTH) values and cortisol response to 250 and 1 μg ACTH stimulation in patients with hyperthyroidism before and after carbimazole therapy: case-control comparative study. J Clin Endocrinol Metab 92:1693–1696. doi:10.1210/jc.2006-2090 CrossRefPubMed Mishra SK, Gupta N, Goswami R (2007) Plasma adrenocorticotropin (ACTH) values and cortisol response to 250 and 1 μg ACTH stimulation in patients with hyperthyroidism before and after carbimazole therapy: case-control comparative study. J Clin Endocrinol Metab 92:1693–1696. doi:10.​1210/​jc.​2006-2090 CrossRefPubMed
14.
Zurück zum Zitat Kamilaris TC, DeBold CR, Johnson EO et al (1991) Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adrenocorticotropin and corticosterone responses to ovine corticotropin-releasing hormone in rats. Endocrinology 128:2567–2576CrossRefPubMed Kamilaris TC, DeBold CR, Johnson EO et al (1991) Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adrenocorticotropin and corticosterone responses to ovine corticotropin-releasing hormone in rats. Endocrinology 128:2567–2576CrossRefPubMed
15.
Zurück zum Zitat Johnson EO, Kamilaris TC, Calogero AE, Gold PW, Chrousos GP (2005) Experimentally-induced hyperthyroidism is associated with activation of the rat hypothalamic-pituitary-adrenal axis. Eur J Endocrinol 153:177–185. doi:10.1530/eje.1.01923 CrossRefPubMed Johnson EO, Kamilaris TC, Calogero AE, Gold PW, Chrousos GP (2005) Experimentally-induced hyperthyroidism is associated with activation of the rat hypothalamic-pituitary-adrenal axis. Eur J Endocrinol 153:177–185. doi:10.​1530/​eje.​1.​01923 CrossRefPubMed
17.
Zurück zum Zitat Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656–660. doi:10.1038/45230 CrossRefPubMed Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656–660. doi:10.​1038/​45230 CrossRefPubMed
20.
Zurück zum Zitat Korbonits M, Kaltsas G, Perry LA et al (1999) The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. J Clin Endocrinol Metab 84:2489–2495. doi:10.1210/jc.84.7.2489 CrossRefPubMed Korbonits M, Kaltsas G, Perry LA et al (1999) The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. J Clin Endocrinol Metab 84:2489–2495. doi:10.​1210/​jc.​84.​7.​2489 CrossRefPubMed
21.
Zurück zum Zitat Arvat E, Maccario M, di Vito L et al (2001) Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 86:1169–1174. doi:10.1210/jc.86.3.1169 CrossRefPubMed Arvat E, Maccario M, di Vito L et al (2001) Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 86:1169–1174. doi:10.​1210/​jc.​86.​3.​1169 CrossRefPubMed
22.
Zurück zum Zitat Coiro V, Saccani-Jotti G, Minelli R et al (2005) Adrenocorticotropin/cortisol and arginine-vasopressin secretory patterns in response to ghrelin in normal men. Neuroendocrinology 81:103–106. doi:10.1159/000085541 CrossRefPubMed Coiro V, Saccani-Jotti G, Minelli R et al (2005) Adrenocorticotropin/cortisol and arginine-vasopressin secretory patterns in response to ghrelin in normal men. Neuroendocrinology 81:103–106. doi:10.​1159/​000085541 CrossRefPubMed
23.
Zurück zum Zitat Correa-Silva SR, Nascif SO, Lengyel AM (2006) Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing’s disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH. Pituitary 9:101–107. doi:10.1007/s11102-006-9149-8 CrossRefPubMed Correa-Silva SR, Nascif SO, Lengyel AM (2006) Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing’s disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH. Pituitary 9:101–107. doi:10.​1007/​s11102-006-9149-8 CrossRefPubMed
24.
Zurück zum Zitat Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF (1995) Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab 80:942–947. doi:10.1210/jc.80.3.942 CrossRefPubMed Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF (1995) Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab 80:942–947. doi:10.​1210/​jc.​80.​3.​942 CrossRefPubMed
27.
Zurück zum Zitat Schleim K-D, Jacks T, Cunningham P et al (1999) Increases in circulating insulin-like growth factor I levels by the oral growth hormone secretagogue MK-0677 in the beagle are dependent upon pituitary mediation. Endocrinology 140:1552–1558. doi:10.1210/en.140.4.1552 CrossRefPubMed Schleim K-D, Jacks T, Cunningham P et al (1999) Increases in circulating insulin-like growth factor I levels by the oral growth hormone secretagogue MK-0677 in the beagle are dependent upon pituitary mediation. Endocrinology 140:1552–1558. doi:10.​1210/​en.​140.​4.​1552 CrossRefPubMed
30.
Zurück zum Zitat Mozid AM, Tringali G, Forsling ML et al (2003) Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin. Horm Metab Res 35:455–459. doi:10.1055/s-2003-41801 CrossRefPubMed Mozid AM, Tringali G, Forsling ML et al (2003) Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin. Horm Metab Res 35:455–459. doi:10.​1055/​s-2003-41801 CrossRefPubMed
32.
Zurück zum Zitat Molica P, Nascif SO, Correa-Silva SR, Silva MR, Sa LBC, Lengyel AMJ (2007) Increased GHRP-6 and ghrelin-induced ACTH release in thyrotoxicosis. Program of the 89th annual meeting of the endocrine society, Toronto, Canada, 2007, pp 348–349 (AbstractP2-89) Molica P, Nascif SO, Correa-Silva SR, Silva MR, Sa LBC, Lengyel AMJ (2007) Increased GHRP-6 and ghrelin-induced ACTH release in thyrotoxicosis. Program of the 89th annual meeting of the endocrine society, Toronto, Canada, 2007, pp 348–349 (AbstractP2-89)
33.
Zurück zum Zitat Davies TF, Larsen PR (2008) Thyrotoxicosis. In: Kronenberg HM (ed) Williams textbook of endocrinology, 11th edn. Saunders Elsevier, Philadelphia, pp 333–375 Davies TF, Larsen PR (2008) Thyrotoxicosis. In: Kronenberg HM (ed) Williams textbook of endocrinology, 11th edn. Saunders Elsevier, Philadelphia, pp 333–375
34.
Zurück zum Zitat Giordano R, Balbo M, Picu A et al (2006) Corticotrope hypersecretion coupled with cortisol hypo-responsiveness to stimuli is present in patients with autoimmune endocrine diseases: evidence for subclinical primary hypoadrenalism? Eur J Endocrinol 155:421–428. doi:10.1530/eje.1.02222 CrossRefPubMed Giordano R, Balbo M, Picu A et al (2006) Corticotrope hypersecretion coupled with cortisol hypo-responsiveness to stimuli is present in patients with autoimmune endocrine diseases: evidence for subclinical primary hypoadrenalism? Eur J Endocrinol 155:421–428. doi:10.​1530/​eje.​1.​02222 CrossRefPubMed
37.
Zurück zum Zitat Thomas GB, Fairhall KM, Robinson ICAF (1997) Activation of the hypothalamic-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Endocrinology 138:1585–1591. doi:10.1210/en.138.4.1585 CrossRefPubMed Thomas GB, Fairhall KM, Robinson ICAF (1997) Activation of the hypothalamic-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Endocrinology 138:1585–1591. doi:10.​1210/​en.​138.​4.​1585 CrossRefPubMed
41.
Metadaten
Titel
Ghrelin and GHRP-6-induced ACTH and cortisol release in thyrotoxicosis
verfasst von
Sergio Oliva Nascif
Patrícia Molica
Silvia Regina Correa-Silva
Marcos Roberto Silva
Ana-Maria Judith Lengyel
Publikationsdatum
01.12.2009
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 4/2009
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-009-0181-3

Weitere Artikel der Ausgabe 4/2009

Pituitary 4/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.